Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 13, 2020, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Tentative Approval for Tavaborole Topical Solution, 5%. ".